FutureChem Co.,Ltd (220100.KQ)

KRW 18200.0

(0.94%)

Net Debt Summary of FutureChem Co.,Ltd

  • FutureChem Co.,Ltd's latest annual net debt in 2023 was -4.93 Billion KRW , down -155.89% from previous year.
  • FutureChem Co.,Ltd's latest quarterly net debt in 2024 Q2 was -2.17 Billion KRW , up 39.37% from previous quarter.
  • FutureChem Co.,Ltd reported annual net debt of 8.82 Billion KRW in 2022, down -41.64% from previous year.
  • FutureChem Co.,Ltd reported annual net debt of 15.11 Billion KRW in 2021, down -19.8% from previous year.
  • FutureChem Co.,Ltd reported quarterly net debt of -3.59 Billion KRW for 2024 Q1, up 27.09% from previous quarter.
  • FutureChem Co.,Ltd reported quarterly net debt of -4.93 Billion KRW for 2023 FY, down -155.89% from previous quarter.

Annual Net Debt Chart of FutureChem Co.,Ltd (2023 - 2016)

Historical Annual Net Debt of FutureChem Co.,Ltd (2023 - 2016)

Year Net Debt Net Debt Growth
2023 -4.93 Billion KRW -155.89%
2022 8.82 Billion KRW -41.64%
2021 15.11 Billion KRW -19.8%
2020 18.84 Billion KRW -43.19%
2019 33.17 Billion KRW -7.05%
2018 35.69 Billion KRW 3254.56%
2017 -1.13 Billion KRW 93.12%
2016 -16.44 Billion KRW 0.0%

Peer Net Debt Comparison of FutureChem Co.,Ltd

Name Net Debt Net Debt Difference
HLB Pharmaceutical Co., Ltd 18.96 Billion KRW 126.004%
CMG Pharmaceutical Co., Ltd. 18.78 Billion KRW 126.249%
Celltrion Pharm, Inc. 142.81 Billion KRW 103.452%
Huons Global Co., Ltd. 13.26 Billion KRW 137.17%
DongKook Pharmaceutical Co., Ltd. 44.19 Billion KRW 111.157%
Enzychem Lifesciences Corporation -9.81 Billion KRW 49.755%
Humedix Co., Ltd. -77.54 Billion KRW 93.642%
Boditech Med Inc. -31.92 Billion KRW 84.556%
EuBiologics Co., Ltd. 4.88 Billion KRW 201.006%
Huons Co., Ltd. 73.9 Billion KRW 106.671%
BNC Korea Co., Ltd. -67.65 Billion KRW 92.712%
AptaBio Therapeutics Inc. -12.08 Billion KRW 59.191%